These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 14978235)
1. Evidence of a functional role for p21WAF1/CIP1 down-regulation in synergistic antileukemic interactions between the histone deacetylase inhibitor sodium butyrate and flavopiridol. Rosato RR; Almenara JA; Yu C; Grant S Mol Pharmacol; 2004 Mar; 65(3):571-81. PubMed ID: 14978235 [TBL] [Abstract][Full Text] [Related]
2. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. Rosato RR; Almenara JA; Grant S Cancer Res; 2003 Jul; 63(13):3637-45. PubMed ID: 12839953 [TBL] [Abstract][Full Text] [Related]
3. The cyclin-dependent kinase inhibitor flavopiridol disrupts sodium butyrate-induced p21WAF1/CIP1 expression and maturation while reciprocally potentiating apoptosis in human leukemia cells. Rosato RR; Almenara JA; Cartee L; Betts V; Chellappan SP; Grant S Mol Cancer Ther; 2002 Feb; 1(4):253-66. PubMed ID: 12467221 [TBL] [Abstract][Full Text] [Related]
4. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells. Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135 [TBL] [Abstract][Full Text] [Related]
5. Coadministration of the heat shock protein 90 antagonist 17-allylamino- 17-demethoxygeldanamycin with suberoylanilide hydroxamic acid or sodium butyrate synergistically induces apoptosis in human leukemia cells. Rahmani M; Yu C; Dai Y; Reese E; Ahmed W; Dent P; Grant S Cancer Res; 2003 Dec; 63(23):8420-7. PubMed ID: 14679005 [TBL] [Abstract][Full Text] [Related]
6. Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA). Almenara J; Rosato R; Grant S Leukemia; 2002 Jul; 16(7):1331-43. PubMed ID: 12094258 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of PI-3 kinase sensitizes human leukemic cells to histone deacetylase inhibitor-mediated apoptosis through p44/42 MAP kinase inactivation and abrogation of p21(CIP1/WAF1) induction rather than AKT inhibition. Rahmani M; Yu C; Reese E; Ahmed W; Hirsch K; Dent P; Grant S Oncogene; 2003 Sep; 22(40):6231-42. PubMed ID: 13679862 [TBL] [Abstract][Full Text] [Related]
8. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors. Pei XY; Dai Y; Grant S Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093 [TBL] [Abstract][Full Text] [Related]
9. Contribution of disruption of the nuclear factor-kappaB pathway to induction of apoptosis in human leukemia cells by histone deacetylase inhibitors and flavopiridol. Gao N; Dai Y; Rahmani M; Dent P; Grant S Mol Pharmacol; 2004 Oct; 66(4):956-63. PubMed ID: 15235103 [TBL] [Abstract][Full Text] [Related]
10. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1). Chopin V; Slomianny C; Hondermarck H; Le Bourhis X Exp Cell Res; 2004 Aug; 298(2):560-73. PubMed ID: 15265702 [TBL] [Abstract][Full Text] [Related]
11. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis. Wang Z; Van Tuyle G; Conrad D; Fisher PB; Dent P; Grant S Cancer Res; 1999 Mar; 59(6):1259-67. PubMed ID: 10096557 [TBL] [Abstract][Full Text] [Related]
12. Evidence of a functional role for the cyclin-dependent kinase-inhibitor p21WAF1/CIP1/MDA6 in promoting differentiation and preventing mitochondrial dysfunction and apoptosis induced by sodium butyrate in human myelomonocytic leukemia cells (U937). Rosato RR; Wang Z; Gopalkrishnan RV; Fisher PB; Grant S Int J Oncol; 2001 Jul; 19(1):181-91. PubMed ID: 11408941 [TBL] [Abstract][Full Text] [Related]
13. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells. Wang Z; Su ZZ; Fisher PB; Wang S; VanTuyle G; Grant S Exp Cell Res; 1998 Oct; 244(1):105-16. PubMed ID: 9770354 [TBL] [Abstract][Full Text] [Related]
14. p53-independent induction of p21(waf1/cip1) contributes to the activation of caspases in GTP-depletion-induced apoptosis of insulin-secreting cells. Huo JX; Metz SA; Li GD Cell Death Differ; 2004 Jan; 11(1):99-109. PubMed ID: 12970678 [TBL] [Abstract][Full Text] [Related]
15. The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells. Jung C; Motwani M; Kortmansky J; Sirotnak FM; She Y; Gonen M; Haimovitz-Friedman A; Schwartz GK Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6052-61. PubMed ID: 14676132 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. Asada M; Yamada T; Ichijo H; Delia D; Miyazono K; Fukumuro K; Mizutani S EMBO J; 1999 Mar; 18(5):1223-34. PubMed ID: 10064589 [TBL] [Abstract][Full Text] [Related]
17. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in human leukemia cells (U937) through the mitochondrial rather than the receptor-mediated pathway. Decker RH; Dai Y; Grant S Cell Death Differ; 2001 Jul; 8(7):715-24. PubMed ID: 11464216 [TBL] [Abstract][Full Text] [Related]
18. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase. Kim H; Kokkotou E; Na X; Rhee SH; Moyer MP; Pothoulakis C; Lamont JT Gastroenterology; 2005 Dec; 129(6):1875-88. PubMed ID: 16344056 [TBL] [Abstract][Full Text] [Related]
19. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor. Sowa Y; Orita T; Minamikawa-Hiranabe S; Mizuno T; Nomura H; Sakai T Cancer Res; 1999 Sep; 59(17):4266-70. PubMed ID: 10485470 [TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]